Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Succinimide Spiro Fused Sultams. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Novel Rh-catalyzed route for anticancer sultams disclosed in CN113444107B. High atom economy, scalable process for pharmaceutical intermediates manufacturing.
Novel rhodium-catalyzed synthesis of anticancer succinimide spiro-sultams offers high efficiency and broad substrate scope for pharmaceutical intermediate manufacturing.